12 research outputs found
Efeito analgésico e anti-inflamatório do extrato aquoso das folhas de trevo-roxo (Scutellaria agrestis A. St.-Hil. ex Benth. - Lamiaceae) em roedores
Oxidability Determination in Waste Waters Using an Automatic Titrator Based on a Multicommutated Unsegmented Flow System
Investigating the separatrices for the runaway threshold of cosmic ray electrons in a thunderstorm atmosphere
USO DE UM DETECTOR POTENCIOMĂTRICO DE SENSIBILIDADE AUMENTADA PARA A DETERMINAĂĂO DE CLORETOS EM LEITE E PRODUTOS LĂCTEOS POR FIA POTENTIOMETRIC FLOW TITRATION WITH INCREASED SENSITIVE DETECTOR FOR DETERMINATION OF CHLORIDES IN MILK AND DAIRY PRODUCTS USO DE UN DETECTOR POTENCIOMĂTRICO DE SENSIBILIDAD AUMENTADA POR FIA PARA LA DETERMINACIĂN DE CLORUROS EN LECHE Y PRODUCTOS LACTEOS
Value of PET imaging for radiation therapy.
This comprehensive review written by experts in their field gives an overview on the current status of incorporating positron emission tomography (PET) into radiation treatment planning. Moreover, it highlights ongoing studies for treatment individualisation and per-treatment tumour response monitoring for various primary tumours. Novel tracers and image analysis methods are discussed. The authors believe this contribution to be of crucial value for experts in the field as well as for policy makers deciding on the reimbursement of this powerful imaging modality
Composição quĂmica e eficĂĄcia do Ăłleo essencial e do extrato etanĂłlico de Alpinia zerumbet sobre Staphylococcus aureus
Anemia and anti-tuberculosis treatment outcome in persons with pulmonary tuberculosis: A multi-center prospective cohort study
Background: Tuberculosis (TB) remains a major plague of humanity. People with TB (PWTB) are commonly anemic. Here, we assessed whether the severity of anemia in PWTB prior to anti-TB treatment (ATT) was a risk factor for an unfavorable outcome. Methods: Patients â„ 18 years old with culture-confirmed drug-susceptible pulmonary TB enrolled between 2015 and 2019 in a multi-center Brazilian cohort were followed for up to 24 months and classified according to anemia severity (mild, moderate, and severe), based on hemoglobin levels. A multinomial logistic regression model was employed to assess whether anemia was associated with unfavorable outcome (death, failure, loss to follow-up, regimen modification or relapse), compared to treatment success (cure or treatment completion). Results: Among 786 participants who met inclusion criteria, 441 (56 %) were anemic at baseline. Patients with moderate/severe anemia were more HIV-seropositive, as well as more symptomatic and had higher frequencies of unfavorable outcomes compared to the other groups. Moderate/severe anemia (adjusted OR [aOR]: 7.80, 95 %CI:1.34â45.4, p = 0.022) was associated with death independent of sex, age, BMI, HIV and glycemic status. Conclusion: Moderate/severe anemia prior to ATT was a significant risk factor for death. Such patients should be closely monitored given the high risk of unfavorable ATT outcomes